More on Delayed Heparin-Induced Thrombocytopenia;Neuropathy with Tumor Necrosis Factor-Alpha Blockers;Anaphylaxis Seen with Multiple Sclerosis Therapy;Dystonia Related to Scabies Therapy Recurrence of PTSD Associated with Antiretroviral Therapy;Clozapine-Induced Agranulocytosis – 11 Years Later!;More Reports of Serious Events with Fluoroquinolones – Seizures and Glycemic Control
Restricted accessResearch articleFirst published online July, 2005
More on Delayed Heparin-Induced Thrombocytopenia;Neuropathy with Tumor Necrosis Factor-Alpha Blockers;Anaphylaxis Seen with Multiple Sclerosis Therapy;Dystonia Related to Scabies Therapy Recurrence of PTSD Associated with Antiretroviral Therapy;Clozapine-Induced Agranulocytosis – 11 Years Later!;More Reports of Serious Events with Fluoroquinolones – Seizures and Glycemic Control
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
ShusterJ.ISMP adverse drug reactions.Hosp Pharm.2001; 36(12): 1235–1236.
2.
ShusterJ.ISMP adverse drug reactions.Hosp Pharm.2002; 37(4): 358–359.
3.
ShusterJ.ISMP adverse drug reactions.Hosp Pharm.2005; 40(1): 18–19.
DamsaC., BandelierC., MarisS.Recurrence of post-traumatic stress disorder and retrovirals.Scand J of Inf Dis.2005; 37(4): 313–316.
9.
SedkyK., ShaughnessyR., HughesT.Clozapine-induced agranulocytosis after 11 years of treatment.Am J Psychiatry.2005; 162(4): 814.
10.
ShusterJ.ISMP adverse drug reactions.Hosp Pharm.2004; 39(3): 207.
11.
ShusterJ.ISMP adverse drug reactions.Hosp Pharm.2001; 36(12): 1239.
12.
BirdS.B., OrrP.G., MazzolaJ.L.Levofloxacin-related seizure activity in a patient with Alzheimer's disease: assessment of potential risk factors.J Clin Psychopharmacol.2005; 25(3): 287–288.
13.
ShusterJ.ISMP adverse drug reactions.Hosp Pharm.2005; 40(2): 129–130.
14.
ShusterJ.ISMP adverse drug reactions.Hosp Pharm.2002; 37(11): 1145–1146.
